Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Le Bras · SciRah

Researcher profile · Semantic Scholar

F. Le Bras

Share profile

F. Le Bras — researcher profile on SciRah

h-index: 20
Works: 100
Citations: 1,770

Most-cited papers

Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin
M. P. Dobay, F. Lemonnier, E. Missiaglia, C. Bastard +17 more
2017Haematologica206 citations Open access
Semantic Scholar
Outcomes of patients with aggressive B-Cell lymphoma after failure of anti-CD19 CAR T-Cell Therapy: A DESCAR-T analysis.
R. Di Blasi, S. le Gouill, E. Bachy, G. Cartron +19 more
2022Blood162 citations Open access
Semantic Scholar
Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets
L. D. de Leval, M. Parrens, F. Le Bras, J. Jais +32 more
2015Haematologica140 citations Open access
Semantic Scholar
Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers
G. Fossard, F. Broussais, I. Coelho, S. Bailly +23 more
2017Annals of Oncology137 citations Open access
Semantic Scholar
Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.
C. Laurent, A. Nicolae, C. Laurent, F. Le Bras +31 more
2019Blood114 citations Open access
Semantic Scholar
Combination of romidepsin with cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated patients with peripheral T-cell lymphoma: a non-randomised, phase 1b/2 study.
J. Dupuis, F. Morschhauser, H. Ghesquières, H. Tilly +14 more
2015The Lancet Haematology103 citations
Semantic Scholar
A prospective phase II of daratumumab in previously treated systemic light chain amyloidosis (AL) patients.
M. Roussel, G. Merlini, S. Chevret, B. Arnulf +16 more
2020Blood92 citations
Semantic Scholar
Rituximab plus gemcitabine and oxaliplatin (R-GemOx) in refractory/relapsed diffuse large B-cell lymphoma: a real-life study in patients ineligible for autologous stem-cell transplantation
C. Cazelles, K. Belhadj, H. Vellemans, V. Camus +15 more
2021Leukemia and Lymphoma43 citations Open access
Semantic Scholar
Plasma cell-directed therapies in monoclonal gammopathy-associated scleromyxedema.
T. Mahévas, B. Arnulf, J. Bouaziz, C. Bulai Livideanu +42 more
2020Blood43 citations
Semantic Scholar
Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Francophone des Myelodysplasies
L. Adès, F. Le Bras, M. Sébert, C. Kelaidi +16 more
2012Haematologica43 citations Open access
Semantic Scholar
Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA study
G. Cartron, R. Houot, Y. Al Tabaa, F. Le Bras +19 more
2025Nature Cancer42 citations Open access
Semantic Scholar
Treatment by Lenalidomide in lower risk myelodysplastic syndrome with 5q deletion--the GFM experience.
F. Le Bras, M. Sébert, C. Kelaidi, T. Lamy +16 more
2011Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis41 citations
Semantic Scholar
Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cell lymphoma
P. Sesques, A. Kirkwood, Mi Kwon, K. Rejeski +34 more
2024Journal of Hematology & Oncology40 citations Open access
Semantic Scholar
Extracardiac soft tissue uptake, evidenced on early 99mTc-HMDP SPECT/CT, helps typing cardiac amyloidosis and demonstrates high prognostic value
Nathan Malka, M. Abulizi, M. Kharoubi, S. Oghina +14 more
2020European Journal of Nuclear Medicine and Molecular Imaging29 citations
Semantic Scholar
Transfusion needs after CAR T-cell therapy for large B-cell lymphoma: predictive factors and outcome (a DESCAR-T study)
S. Vic, J. Thibert, E. Bachy, G. Cartron +18 more
2024Blood Advances28 citations Open access
Semantic Scholar
History of extracardiac/cardiac events in cardiac amyloidosis: prevalence and time from initial onset to diagnosis
M. Kharoubi, M. Bézard, A. Galat, F. Le Bras +21 more
2021ESC Heart Failure28 citations Open access
Semantic Scholar
Clinical spectrum, evolution, and management of autoimmune cytopenias associated with angioimmunoblastic T‐cell lymphoma
É. Crickx, E. Poullot, G. Moulis, R. Goulabchand +18 more
2019European Journal of Haematology26 citations
Semantic Scholar
Spectrum of adult Parvovirus B19 infection according to the underlying predisposing condition and proposals for clinical practice
A. Wolfromm, C. Rodriguez, M. Michel, A. Habibi +12 more
2015British Journal of Haematology24 citations Open access
Semantic Scholar
Assessing Cardiac Amyloidosis Subtypes by Unsupervised Phenotype Clustering Analysis.
L. Bonnefous, M. Kharoubi, M. Bézard, S. Oghina +9 more
2021Journal of the American College of Cardiology22 citations Open access
Semantic Scholar
Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registry
C. Herbaux, C. Bret, E. Bachy, P. Bories +24 more
2024Haematologica21 citations Open access
Semantic Scholar
Venetoclax induces profound and sustained responses in patients with relapsed/refractory light‐chain amyloidosis
Hélène Pasquer, K. Belhadj, J. Dupuis, S. Oghina +12 more
2021British Journal of Haematology18 citations
Semantic Scholar
Outcomes of patients with relapsed or refractory primary mediastinal B‐cell lymphoma treated with anti‐CD19 CAR‐T cells: CARTHYM, a study from the French national DESCAR‐T registry
Jean Galtier, Charles Mesguich, P. Sesques, Vivien Dupont +23 more
2025HemaSphere17 citations Open access
Semantic Scholar
Sequential cyclophosphamide-bortezomib-dexamethasone unmasks the harmful cardiac effect of dexamethasone in primary light-chain cardiac amyloidosis.
F. Le Bras, V. Molinier-Frenkel, A. Guellich, J. Dupuis +9 more
2017European Journal of Cancer17 citations
Semantic Scholar
CD30 as a therapeutic target in adult haematological malignancies: Where are we now?
M. Veyri, J. Spano, F. Le Bras, A. Marcelin +1 more
2023British Journal of Haematology15 citations Open access
Semantic Scholar
Glofitamab Monotherapy in Patients with Non-Hodgkin B-Cell Lymphoma after Failing CAR T-Cell Infusion: Primary Analysis of the Bicar Study, a Phase II Lysa Study
P. Sesques, R. Houot, Y. Al Tabaa, F. Le Bras +18 more
2023Blood15 citations Open access
Semantic Scholar
Revisiting the spectrum of IgM-related neuropathies in a large cohort of IgM monoclonal gammopathy
B. Bardel, V. Molinier-Frenkel, F. Le Bras, S. Ayache +3 more
2022Journal of Neurology15 citations
Semantic Scholar
Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement
M. Bézard, S. Oghina, D. Vitiello, M. Kharoubi +15 more
2021PLoS ONE15 citations Open access
Semantic Scholar
Optimization of whole-body 2-[18F]FDG-PET/MRI imaging protocol for the initial staging of patients with myeloma
Robert Burns, S. Mulé, P. Blanc-Durand, Mojdeh Tofighi +7 more
2021European Radiology15 citations
Semantic Scholar
Colonic mucosa-associated lymphoid tissue lymphoma: a case series
J. Tannoury, A. Amiot, F. Lemonnier, J. Dupuis +7 more
2019Leukemia and Lymphoma15 citations
Semantic Scholar
Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study
E. Réboursière, F. Le Bras, C. Herbaux, E. Gyan +30 more
2016OncoTarget15 citations Open access
Semantic Scholar
Real World Data of Axicabtagene Ciloleucel As Second Line Therapy for Patients with Large B Cell Lymphoma: First Results of a Lysa Study from the French Descar-T Registry
G. Brisou, G. Cartron, E. Bachy, C. Thieblemont +22 more
2023Blood14 citations Open access
Semantic Scholar
Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study
A. Stamatoullas, H. Ghesquières, P. Feugier, M. André +13 more
2022Leukemia and Lymphoma14 citations Open access
Semantic Scholar
Carfilzomib, venetoclax and dexamethasone for relapsed/refractory multiple myeloma
Clémentine Boccon-Gibod, A. Talbot, F. Le Bras, L. Frenzel +6 more
2020British Journal of Haematology13 citations Open access
Semantic Scholar
[Cardiac amyloidosis: How to recognize them and manage them?]
D. Bodez, A. Galat, A. Guellich, J. Deux +12 more
2016Presse medicale13 citations
Semantic Scholar
Anti-SARS-CoV-2 antibody response after 2 and 3 doses of BNT162b2 mRNA vaccine in patients with lymphoid malignancies
S. B. Gressens, S. Fourati, A. Le Bouter, F. Le Bras +10 more
2022Clinical Microbiology and Infection12 citations Open access
Semantic Scholar
Echocardiographic Patterns of Left Ventricular Diastolic Function in Cardiac Amyloidosis: An Updated Evaluation
S. Oghina, W. Bougouin, M. Kharoubi, L. Bonnefous +12 more
2021Journal of Clinical Medicine11 citations Open access
Semantic Scholar
Prognostic mortality factors in advanced light chain cardiac amyloidosis: A prospective cohort study
A. Zaroui, M. Kharoubi, R. Gounot, S. Oghina +17 more
2024ESC Heart Failure10 citations Open access
Semantic Scholar
Heart Transplantation, Either Alone or Combined With Liver and Kidney, a Viable Treatment Option for Selected Patients With Severe Cardiac Amyloidosis
S. Guendouz, P. Grimbert, C. Radu, D. Cherqui +24 more
2022Transplantation Direct10 citations Open access
Semantic Scholar
Venetoclax induces sustained complete responses in refractory/relapsed patients with cardiac AL amyloidosis.
F. Le Bras, J. Dupuis, F. Lemonnier, S. Oghina +9 more
2019Journal of Clinical Oncology10 citations
Semantic Scholar
Rate and characteristics of inflammatory neuropathies associated with brentuximab vedotin therapy
Arthur Matthys, B. Bardel, F. Le Bras, A. Créange +8 more
2024European Journal of Neurology8 citations Open access
Semantic Scholar
Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study
F. Andreozzi, M. Dragani, C. Quivoron, F. Le Bras +8 more
2023Cancers8 citations Open access
Semantic Scholar
Renal Infarction and Its Consequences for Renal Function in Patients With Cardiac Amyloidosis.
Julien Dang, M. Abulizi, A. Moktefi, K. El Karoui +14 more
2019Mayo Clinic proceedings8 citations Open access
Semantic Scholar
Invasive Fungal Infections after CD19 CAR T-cell Therapy for B-Cell Lymphoma: a LYSA study from the DESCAR-T Registry.
Amélie Bouvier, Amandine Durand, Vivien Dupont, N. Gower +20 more
2025Clinical Microbiology and Infection7 citations Open access
Semantic Scholar
Outcome of Relapsed/Refractory Aggressive B-Cell Lymphoma Patients Relapsing after Anti-CD19 CAR T-Cells and Enrolled in the Descar-T French National Registry
R. Di Blasi, S. le Gouill, E. Bachy, G. Cartron +19 more
2021Blood7 citations Open access
Semantic Scholar
Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairment
R. Gounot, F. Le Bras, J. Dupuis, S. Oghina +11 more
2020Leukemia and Lymphoma7 citations
Semantic Scholar
Invasive Fungal Infections after CAR T-Cell Therapy for B-Cell Lymphoma: A Study from the French Descart Registry
Amélie Bouvier, Amandine Durand, N. Gower, C. Castilla-Llorente +18 more
2023Blood6 citations
Semantic Scholar
Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials
S. Juul, S. Rossetti, M. Kicinski, M. V. D. van der Kaaij +16 more
2023Acta oncologica6 citations Open access
Semantic Scholar
Employment situation among long-term Hodgkin lymphoma survivors in Europe: an analysis of patients from nine consecutive EORTC-LYSA trials
S. Juul, S. Rossetti, M. Kicinski, M. V. D. van der Kaaij +16 more
2022Journal of cancer survivorship6 citations Open access
Semantic Scholar
Effectiveness and Safety of Subcutaneous Rituximab for Patients With Gastric MALT Lymphoma: A Case-Control Comparison With Intravenous Rituximab.
H. Rotkopf, Michaël Lévy, C. Copie-Bergman, J. Dupuis +9 more
2020Clinical Lymphoma, Myeloma & Leukemia6 citations Open access
Semantic Scholar
Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL): The French Lymphoma Study Association (LYSA) Registry Data
F. Le Bras, C. Laurent, R. Bosc, Lionel Tortelano +17 more
2018Blood6 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Haioun×12
Invite
C. Haioun — researcher profile on SciRah
R. Houot×12
Invite
R. Houot — researcher profile on SciRah
K. Belhadj×12
Invite
K. Belhadj — researcher profile on SciRah
E. Bachy×11
Invite
E. Bachy — researcher profile on SciRah

×11

Invite

O. Casasnovas — researcher profile on SciRah

T. Gastinne×11

Invite

T. Gastinne — researcher profile on SciRah

Invite

T. Damy — researcher profile on SciRah

Invite

J. Dupuis — researcher profile on SciRah

Invite

S. Oghina — researcher profile on SciRah

F. Lemonnier×9

Invite

F. Lemonnier — researcher profile on SciRah

Invite

G. Cartron — researcher profile on SciRah

Invite

M. Joris — researcher profile on SciRah